Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

EndoMune Introduces Children’s Probiotic in New Bottle, Only Probiotic to Be Parent Tested and Parent Approved
  • USA - English


News provided by

EndoMune Advanced Probiotic

Nov 14, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

San Antonio (PRWEB) November 14, 2014 -- EndoMune Advanced Junior, the only probiotic created by a gastroenterologist, is launching a new and improved bottle, no longer requiring refrigeration just in time for November’s National Diabetes Awareness Month.

EndoMune Advanced Junior is the only probiotic for children that is Parent Tested and Parent Approved (PTPA). All-natural, vegan-friendly, non-GMO and gluten-free , EndoMune Advanced Junior was formulated to protect children from problematic intestinal bacteria linked to obesity and the development of Type 2 diabetes.

“Research has shown the benefits of probiotics for children in many capacities, one being the prevention of obesity,” said Dr. Lawrence Hoberman of Endomune. “This new bottle makes it much easier for both parents and children to work a probiotic regimen into their daily routine.”

A two-month supply of EndoMune Junior now comes in an innovative bottle that protects against humidity to keep beneficial bacteria live without refrigeration. Each serving contains 10 billion bacteria from four beneficial strains including Bifidobacteria, Lactobacilli, Prebiotic and Streptococcus.

In contrast, the majority of over-the-counter probiotics provide only 1 to 10 billion bacteria per serving and typically just one strain. This probiotic is beneficial for all children between the ages of infancy to eight-years-old. It is dairy- and soy-free powder and, unlike chewable products, completely natural.

“This product was very easy to use; I really like the scoop that came with the product. It gave my oldest a chance to scoop it out herself and know she got it right. I also like how you just put it directly into the kids drink instead of having them take a pill every day,” described one mom.

EndoMune has grown rapidly since Dr. Hoberman founded the company in 2007 in San Antonio, Texas. The award-winning physician, who continues to practice preventative medicine, developed the probiotic with help from a microbiologist after seeking ways to address Crohn’s disease, inflammatory bowel disease and other health conditions connected to digestion.

Thanks to positive patient reviews and recommendations by physicians, dentists, nutritionists and chiropractors, the company has become a preferred probiotic in the South Texas market. Available on Amazon.com and at select pharmacies and health food stores, EndoMune Junior is expanding to other brick-and-mortar stores across the country. Visit http://www.endomune.com to read Dr. Hoberman’s blogs and view videos where he discusses the role of probiotics and the human microbiome in overall health.

                                                                    ###

About Dr. Lawrence Hoberman: Lawrence Hoberman, M.D. has spent more than 40 years practicing medicine and is board certified in both Internal Medicine (1972) and Gastroenterology (1975). His passion to help people enjoy good health throughout their lifetimes led Dr. Hoberman to develop his own effective probiotic supplement: EndoMune Advanced Probiotic. Many individuals suffer from ongoing GI symptoms, allergies and skin conditions that may benefit from the addition of a daily probiotic supplement. Since its creation, EndoMune Advanced Probiotic has proven a helpful health and wellness ally for individuals across the country. Dr. Hoberman currently sees patients as a part of a health and wellness practice that stresses preventative medicine. He is currently in practice at Health by Design, located in San Antonio, Texas.

About EndoMune Advanced Probiotic: EndoMune Advanced Adult Probiotic and EndoMune Advanced Junior are the only two probiotics on the market that have been developed by a board certified gastroenterologist. After much research, Dr. Hoberman, in collaboration with a PhD-level microbiologist, created these two proprietary blends of multi-strain, multi-species probiotic bacteria. Both of the EndoMune Advanced Adult Probiotic and EndoMune Advanced Junior strains of probiotic bacteria are safe and effective. A healthy intestinal balance of bacteria has a major effect on overall health. Each serving of EndoMune delivers a sufficient number of probiotic bacteria (10 billion in EndoMune Advanced Junior and 16 billion in EndoMune Advanced Adult Probiotic) to ensure improved intestinal digestion and immune system function. EndoMune Advanced Probiotic for adults is non-dairy, no artificial colorings, no preservatives, no sugar, gluten free and certified Kosher.

Dr. Lawrence Hoberman, EndoMune Advanced Probiotic, http://endomune.com, +1 2103488008, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.